New Insights into the Role of KLF10 in Tissue Fibrosis

New Insights into the Role of KLF10 in Tissue Fibrosis

Fibrosis, characterized by excessive extracellular matrix accumulation, disrupts normal tissue architecture, causes organ dysfunction, and contributes to numerous chronic diseases. This review focuses on Krüppel-like factor 10 (KLF10), a transcription factor significantly induced by transforming gro...

Full description

Bibliographic Details
Main Authors:	Uzma Yaseen, Soonjae Hwang, Sangbin Park, Soo-Bin Kim, Ho-Jae Lee, Ji-Young Cha
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	International Journal of Molecular Sciences
Subjects:	fibrosis Krüppel-like factor 10 TGF-β NAFLD NASH
Online Access:	https://www.mdpi.com/1422-0067/25/2/1276

Similar Items

KLF10 Inhibits TGF-β-Mediated Activation of Hepatic Stellate Cells via Suppression of ATF3 Expression
by: Soonjae Hwang, et al.
Published: (2023-08-01)

Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding
by: Junghoon Lee, et al.
Published: (2020-12-01)

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
by: Wei-Qiang Leow, et al.
Published: (2020-08-01)

Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
by: Ahmed Samir Allam, et al.
Published: (2020-01-01)

Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
by: Antonella Mosca, et al.
Published: (2022-04-01)

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Francesco Vizzutti;, et al.
Published: (2009-04-01)

Overexpression of KLF4 Suppresses Pulmonary Fibrosis through the HIF-1α/Endoplasmic Reticulum Stress Signaling Pathway
by: Shanchen Wei, et al.
Published: (2023-09-01)

High Expression of KLF10 Is Associated with Favorable Survival in Patients with Oral Squamous Cell Carcinoma
by: Chung-Min Yeh, et al.
Published: (2020-12-01)

Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways
by: Eduardo E. Vargas-Pozada, et al.
Published: (2022-03-01)

Factores analíticos, antropométricos y dietéticos asociados al desarrollo de fibrosis en pacientes con enfermedad por hígado graso no alcohólico
by: Sara Gómez-de-la-Cuesta, et al.

Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis
by: Jin-Zhong Li, et al.
Published: (2023-12-01)

The role of KLF transcription factor in the regulation of cancer progression
by: Zi-Yi Li, et al.
Published: (2023-06-01)

Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease
by: Sachiyo Yoshio, et al.
Published: (2021-07-01)

KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism
by: Anthony A Ruberto, et al.
Published: (2021-08-01)

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
by: Jian Huang, et al.
Published: (2023-04-01)

SP and KLF Transcription Factors in Cancer Metabolism
by: Emilia J. Orzechowska-Licari, et al.
Published: (2022-09-01)

The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy
by: Siarhei A. Dabravolski, et al.
Published: (2022-01-01)

Type IV collagen as marker of fibrosis in nonalcoholic liver disease
by: Alvina
Published: (2010-08-01)

Evaluación de fibrosis en pacientes con enfermedad por hígado graso no alcohólico: adherencia a los algoritmos propuestos y barreras para cumplir con ellos
by: S. Marciano, et al.
Published: (2022-01-01)

Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse
by: Silvia Sookoian, et al.
Published: (2018-03-01)

KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression
by: Xiangchen Gu, et al.
Published: (2017-11-01)

Interleukin-13 (IL-13)—A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis
by: Elke Roeb
Published: (2023-08-01)

High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients
by: Juan P. Arab, et al.
Published: (2016-09-01)

KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling
by: Azra Memon, et al.
Published: (2018-05-01)

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
by: Anita M. van den Hoek, et al.
Published: (2020-09-01)

Production, Exacerbating Effect, and EV-Mediated Transcription of Hepatic CCN2 in NASH: Implications for Diagnosis and Therapy of NASH Fibrosis
by: Xinlei Li, et al.
Published: (2023-08-01)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
by: Tran Thi Khanh Tuong, et al.
Published: (2020-03-01)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
by: Rocío Gallego-Durán, et al.
Published: (2021-11-01)

Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma
by: Yi-Chih Tsai, et al.
Published: (2023-10-01)

Common Transcriptional Program of Liver Fibrosis in Mouse Genetic Models and Humans
by: Kaja Blagotinšek Cokan, et al.
Published: (2021-01-01)

Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis
by: Tanat Yongpisarn, et al.
Published: (2022-12-01)

Imaging biomarkers of NAFLD, NASH, and fibrosis
by: Veeral Ajmera, et al.
Published: (2021-08-01)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01)

Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease
by: Jingjing Jiao, et al.
Published: (2023-02-01)

TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis
by: Cheol Ho Park, et al.
Published: (2022-11-01)

TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
by: Jeff Yat-Fai Chung, et al.
Published: (2021-07-01)

A continuous-time Markov chain model of fibrosis progression in NAFLD and NASH
by: Lyndsey F. Meyer, et al.
Published: (2023-05-01)

Loss of Krüppel-like factor-10 facilitates the development of chemical-induced liver cancer in mice
by: Sung Hwan Yoo, et al.
Published: (2023-11-01)

Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01)

Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation
by: José A. Inia, et al.
Published: (2023-04-01)